Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Association between physical activity and cardiovascular risk factors: dose and sex matter

  • Santos-Lozano, A.
  • Torres Barrán, Alberto
  • Fernández-Navarro, Pablo
  • Valenzuela, P.L.
  • Castillo-Garcia, A.
  • Ruilope, L. M.
  • Ríos Insua, David
  • Ordovás, José M.
  • Ley, Victoria
  • Lucía, Alejandro
descripción no proporcionada por scopus, We sincerely appreciate the collaboration of Quirónprevención, which provided the anonymized data used in this study and provided support on analyses and interpretation. Research on physical activity by ASL is funded by grants from the Spanish Ministry of Economy and Competitiveness and Fondos FEDER (Fondo de Investigaciones Sanitarias (FIS), grant numbers PI15/00558 and PI18/00139).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Genetic factors and Waldenström's macroglobulinemia: Systematic review and meta-analysis

  • Santos-Lozano, Alejandro
  • Rueda-González, Jesús
  • Martín-Hernández, Juan
  • Serna-Molpereces, Jorge
  • Cristi-Montero, Carlos
  • Fiuza-Luces, Carmen
  • Baladrón, Carlos
  • Pinto-Fraga, José
  • Garatachea, Nuria
  • Cedena, María Teresa
  • Martínez-López, Joaquín
  • Lucia, Alejandro
Waldenström's macroglobulinemia (WM) is categorized as a B-cell neoplasia characterized by lymphoplasmacytic infiltration in the bone marrow and the overproduction of serum monoclonal IgM. The precise cause of WM is unknown, but familial patterns suggest the possibility of an underlying genetic defect. The purpose of this study was to determine the association between different gene variations and the development of WM. We studied different genetic variations reporting significant incidence rates. The most representative of those were the MYD88 (L256P) mutation with an incidence rate of 81% and 6q deletion with an incidence rate of 36%. In addition, CXCR4 mutation, 13q14 deletion and trisomy 4 showed an incidence rate of 29%, 12% and 14%, respectively. Finally, the deletion 17p13 was present in 8% of subjects. Our results suggest that the MYD88 (L256P) mutation might be a target for the development of specific therapeutic strategies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Three-dimensional imaging in myotonic dystrophy type 1

  • Ballester-Lopez, Alfonsina|||0000-0002-8922-1664
  • Núñez-Manchón, Judit|||0000-0001-5154-1454
  • Koehorst, Emma
  • Linares-Pardo, Ian
  • Almendrote, Míriam|||0000-0003-0212-275X
  • Lucente, Giuseppe|||0000-0003-1120-9136
  • Guanyabens Busca, Nicolau|||0000-0002-2074-2744
  • Lopez-Osias, Marta
  • Suárez-Mesa, Adrián
  • Hanick, Shaliza Ann
  • Chojnacki, Jakub|||0000-0002-4457-8096
  • Lucia, Alejandro|||0000-0002-3025-2060
  • Pintos-Morell, Guillem|||0000-0002-9347-2386
  • Coll-Cantí, Jaume|||0000-0001-7128-1186
  • Martínez-Piñeiro, Alicia|||0000-0003-1988-606X
  • Ramos-Fransi, Alba|||0000-0002-4114-4575
  • Nogales, Gisela|||0000-0002-7414-212X
We aimed to determine whether 3D imaging reconstruction allows identifying molecular:clinical associations in myotonic dystrophy type 1 (DM1). We obtained myoblasts from 6 patients with DM1 and 6 controls. We measured cytosine-thymine-guanine (CTG) expansion and detected RNA foci and muscleblind like 1 (MBNL1) through 3D reconstruction. We studied dystrophia myotonica protein kinase (DMPK) expression and splicing alterations of MBNL1, insulin receptor, and sarcoplasmic reticulum Ca(2+)-ATPase 1. Three-dimensional analysis showed that RNA foci (nuclear and/or cytoplasmic) were present in 45%-100% of DM1-derived myoblasts we studied (range: 0-6 foci per cell). RNA foci represented <0.6% of the total myoblast nuclear volume. CTG expansion size was associated with the number of RNA foci per myoblast (r = 0.876 [95% confidence interval 0.222-0.986]) as well as with the number of cytoplasmic RNA foci (r = 0.943 [0.559-0.994]). Although MBNL1 colocalized with RNA foci in all DM1 myoblast cell lines, colocalization only accounted for 1% of total MBNL1 expression, with the absence of DM1 alternative splicing patterns. The number of RNA foci was associated with DMPK expression (r = 0.967 [0.079-0.999]). On the other hand, the number of cytoplasmic RNA foci was correlated with the age at disease onset (r = -0.818 [-0.979 to 0.019]). CTG expansion size modulates RNA foci number in myoblasts derived from patients with DM1. MBNL1 sequestration plays only a minor role in the pathobiology of the disease in these cells. Higher number of cytoplasmic RNA foci is related to an early onset of the disease, a finding that should be corroborated in future studies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sex Differences and the Influence of an Active Lifestyle on Adiposity in Patients with McArdle Disease

  • Rodríguez-Gómez, Irene|||0000-0002-1622-7109
  • Santalla, Alfredo|||0000-0001-9418-0564
  • Díez Bermejo, Jorge
  • Munguía-Izquierdo, Diego|||0000-0001-7817-747X
  • Alegre, Luis M.|||0000-0002-4502-9275
  • Nogales, Gisela|||0000-0002-7414-212X
  • Arenas, Joaquín|||0000-0002-2877-5049
  • Martín, Miguel A.|||0000-0003-4741-772X
  • Lucia, Alejandro|||0000-0002-3025-2060
  • Ara, Ignacio|||0000-0002-2854-6684
McArdle disease (glycogenosis-V) is associated with exercise intolerance, however, how it affects an important marker of cardiometabolic health as it is adiposity remains unknown. We evaluated the association between physical activity (PA) and adiposity in patients with McArdle disease. We assessed 199 adults of both sexes (51 McArdle patients (36 ± 11 years) and 148 healthy controls (35 ± 10 years)). Body fat (BF) was determined using dual-energy X-ray absorptiometry (DXA) method and each patient's PA was assessed with the International PA Questionnaire (IPAQ). Although body mass index values did not differ between patients and controls, McArdle patients had significantly higher values of BF in all body regions (p < 0.05) and higher risk of suffering obesity (odds ratio (OR): 2.54, 95% confidence interval (95% CI): 1.32-4.88). Male patients had higher BF and obesity risk (OR: 3.69, 95% CI: 1.46-9.34) than their sex-matched controls, but no differences were found within the female sex (p < 0.05). In turn, active female patients had lower trunk BF than their inactive peers (p < 0.05). Males with McArdle seem to have adiposity problems and a higher risk of developing obesity than people without the condition, while female patients show similar or even better levels in the trunk region with an active lifestyle. Therefore, special attention should be given to decrease adiposity and reduce obesity risk in males with McArdle disease.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Preliminary Findings on CTG Expansion Determination in Different Tissues from Patients with Myotonic Dystrophy Type 1

  • Ballester-Lopez, Alfonsina|||0000-0002-8922-1664
  • Koehorst, Emma
  • Linares-Pardo, Ian
  • Núñez-Manchón, Judit|||0000-0001-5154-1454
  • Almendrote, Míriam|||0000-0003-0212-275X
  • Lucente, Giuseppe|||0000-0003-1120-9136
  • Arbex, Andrea|||0000-0002-3741-4755
  • Puente-Alonso, Carles
  • Lucia, Alejandro|||0000-0002-3025-2060
  • Monckton, Darren G.|||0000-0002-8298-8264
  • Cumming, Sarah A.|||0000-0002-0201-3660
  • Pintos-Morell, Guillem|||0000-0002-9347-2386
  • Coll-Cantí, Jaume|||0000-0001-7128-1186
  • Ramos-Fransi, Alba|||0000-0002-4114-4575
  • Martínez-Piñeiro, Alicia|||0000-0003-1988-606X
  • Nogales, Gisela|||0000-0002-7414-212X
Myotonic Dystrophy type 1 (DM1) is characterized by a high genetic and clinical variability. Determination of the genetic variability in DM1 might help to determine whether there is an association between CTG (Cytosine-Thymine-Guanine) expansion and the clinical manifestations of this condition. We studied the variability of the CTG expansion (progenitor, mode, and longest allele, respectively, and genetic instability) in three tissues (blood, muscle, and tissue) from eight patients with DM1. We also studied the association of genetic data with the patients' clinical characteristics. Although genetic instability was confirmed in all the tissues that we studied, our results suggest that CTG expansion is larger in muscle and skin cells compared with peripheral blood leukocytes. While keeping in mind that more research is needed in larger cohorts, we have provided preliminary evidence suggesting that the estimated progenitor CTG size in muscle could be potentially used as an indicator of age of disease onset and muscle function impairment.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Absence of p.R50X Pygm read-through in McArdle disease cellular models

  • Tarrasó, Guillermo
  • Real-Martinez, Alberto|||0000-0002-4703-5142
  • Parés, Marta
  • Romero-Cortadellas, Lídia|||0000-0003-1080-3774
  • Puigros, Laura
  • Moya Borrego, Laura|||0000-0002-2630-7911
  • Luna Salva, Noemí de|||0000-0002-4342-794X
  • Brull, Astrid|||0000-0002-3012-451X
  • Martín, Miguel A.|||0000-0003-4741-772X
  • Arenas, Joaquín|||0000-0002-2877-5049
  • Lucia, Alejandro|||0000-0002-3025-2060
  • Andreu Périz, Antoni Lluís
  • Barquinero Mañez, Jordi|||0000-0002-1677-9851
  • Vissing, John|||0000-0001-6144-8544
  • Krag, Thomas|||0000-0001-9330-668X
  • Pinós Figueras, Tomàs|||0000-0002-4379-0917
McArdle disease is an autosomal recessive disorder caused by the absence of muscle glycogen phosphorylase, which leads to blocked muscle glycogen breakdown. We used three different cellular models to evaluate the efficiency of different read-through agents (including amlexanox, Ataluren, RTC13 and G418) in McArdle disease. The first model consisted of HeLa cells transfected with two different GFP- PYGM constructs presenting the Pygm p.R50X mutation (GFP- PYGM p.R50X and PYGM Ex1-GFP p.R50X). The second cellular model was based on the creation of HEK293T cell lines stably expressing the PYGM Ex1-GFP p.R50X construct. As these plasmids encode murine Pygm cDNA without any intron sequence, their transfection in cells would allow for analysis of the efficacy of read-through agents with no concomitant nonsense-mediated decay interference. The third model consisted of skeletal muscle cultures derived from the McArdle mouse model (knock-in for the p.R50X mutation in the Pygm gene). We found no evidence of read-through at detectable levels in any of the models evaluated. We performed a literature search and compared the premature termination codon context sequences with reported positive and negative read-through induction, identifying a potential role for nucleotide positions -9, -8, -3, -2, +13 and +14 (the first nucleotide of the stop codon is assigned as +1). The Pygm p.R50X mutation presents TGA as a stop codon, G nucleotides at positions -1 and -9, and a C nucleotide at -3, which potentially generate a good context for read-through induction, counteracted by the presence of C at -2 and its absence at +4. Summary: Here, we evaluated the efficiency of different read-through agents in McArdle disease cell culture models, revealing that read-through compounds do not restore full-length muscle glycogen phosphorylase.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genotypic and phenotypic features of all Spanish patients with McArdle disease, a 2016 update

  • Santalla, Alfredo|||0000-0001-9418-0564
  • Nogales, Gisela|||0000-0002-7414-212X
  • Encinar, Alberto Blazquez
  • Vieitez, Irene
  • González-Quintana, Adrian
  • Serrano-Lorenzo, Pablo|||0000-0002-5661-7574
  • Consuegra-García, Inés
  • Asensio-Peña, Sara|||0000-0002-2048-5899
  • Ballester-Lopez, Alfonsina|||0000-0002-8922-1664
  • Pintos-Morell, Guillem|||0000-0002-9347-2386
  • Coll-Cantí, Jaume|||0000-0001-7128-1186
  • Pareja-Galeano, Helios
  • Díez Bermejo, Jorge
  • Pérez Ruiz, Margarita|||0000-0001-7240-2082
  • Andreu Périz, Antoni Lluís
  • Pinós Figueras, Tomàs|||0000-0002-4379-0917
  • Arenas, Joaquín|||0000-0002-2877-5049
  • Martín, Miguel A.|||0000-0003-4741-772X
  • Lucia, Alejandro|||0000-0002-3025-2060
We recently described the genotype/phenotype features of all Spanish patients diagnosed with McArdle disease as of January 2011 (n = 239, prevalence of ~1/167,000) (J Neurol Neurosurg Psychiatry 2012;83:322-8). Several caveats were however identified suggesting that the prevalence of the disease is actually higher. We have now updated main genotype/phenotype data, as well as potential associations within/between them, of all Spanish individuals currently diagnosed with McArdle disease (December 2016). Ninety-four new patients (all Caucasian) have been diagnosed, yielding a prevalence of ~1/139,543 individuals. Around 55% of the mutated alleles have the commonest PYGM pathogenic mutation p.R50X, whereas p.W798R and p.G205S account for 10 and 9% of the allelic variants, respectively. Seven new mutations were identified: p.H35R, p.R70C, p.R94Q, p.L132WfsX163, p.Q176P, p.R576Q, and c.244-3_244-2CA. Almost all patients show exercise intolerance, the second wind phenomenon and high serum creatine kinase activity. There is, however, heterogeneity in clinical severity, with 8% of patients being asymptomatic during normal daily life, and 21% showing limitations during daily activities and fixed muscle weakness. A major remaining challenge is one of diagnosis, which is often delayed until the third decade of life in 72% of new patients despite the vast majority (86%) reporting symptoms before 20 years. An important development is the growing proportion of those reporting a 4-year improvement in disease severity (now 34%) and following an active lifestyle (50%). Physically active patients are more likely to report an improvement after a 4-year period in the clinical course of the disease than their inactive peers (odds ratio: 13.98; 95% confidence interval: 5.6, 34.9; p < 0.001). Peak oxygen uptake is also higher in the former (20.7 ± 6.0 vs. 16.8 ± 5.3 mL/kg/min, p = 0.0013). Finally, there is no association between PYGM genotype and phenotype manifestation of the disease. The reported prevalence of McArdle disease grows exponentially despite frequent, long delays in genetic diagnosis, suggesting that many patients remain undiagnosed. Until a genetic cure is available (which is not predicted in the near future), current epidemiologic data support that adoption of an active lifestyle is the best medicine for these patients.